# Inhaled Ibuprofen to Treat COVID-19

> **NCT04382768** · NA · UNKNOWN · sponsor: **Química Luar SRL** · enrollment: 40 (estimated)

## Conditions studied

- Coronavirus Infection
- Respiratory Disease
- SARS (Disease)

## Interventions

- **DRUG:** Inhaled Hypertonic ibuprofen

## Key facts

- **NCT ID:** NCT04382768
- **Lead sponsor:** Química Luar SRL
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2021-01
- **Final completion:** 2021-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-06-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04382768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04382768, "Inhaled Ibuprofen to Treat COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04382768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*